SEC Info - Nu Skin Enterprises, Inc.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM i 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

	i July 7, 2022
	Date of Report (Date of earliest event reported)

	i NU SKIN ENTERPRISES, INC.
	(Exact name of registrant as specified in its charter)

i Delaware		i 001-12421	i 87-0565309
(State or other jurisdiction of incorporation)		(Commission File Number)	(IRS Employer Identification Number)

	i 75 West Center Street i Provo, i Utah i 84601
	(Address of principal executive offices and zip code)

	( i 801) i 345-1000
	(Registrant’s telephone number, including area code)

	N/A
	(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

i ☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

i ☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
i Class A Common Stock, $.001 par value	i NUS	i New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02

Results of Operations and Financial Condition.

On July 7, 2022, Nu Skin Enterprises, Inc. issued a press release announcing preliminary information about its financial results for the three-month period ended June 30, 2022, and certain other information. A copy of the press release is attached as Exhibit 99.1 to this report.

The information furnished pursuant to this Item 2.02 and Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing.

Item 9.01

Financial Statements and Exhibits.

(d)

Exhibits.

99.1	Nu Skin Enterprises’ press release dated July 7, 2022, regarding preliminary financial results for the three-month period ended June 30, 2022.

104	Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	NU SKIN ENTERPRISES, INC.
	(Registrant)

	/s/ *Mark H. Lawrence*
	Mark H. Lawrence
	Chief Financial Officer
Date: July 8, 2022

This ‘8-K’ Filing	Date	Other Filings

Filed on:	7/8/22	None on these Dates
For Period end:	7/7/22
	6/30/22
		List all Filings

Nu Skin Enterprises, Inc. – ‘8-K’ for 7/7/22

On: Friday, 7/8/22, at 4:05pm ET · For: 7/7/22 · Accession #: 1140361-22-25598 · File #: 1-12421

Previous ‘8-K’: ‘8-K’ on 6/17/22 for 6/14/22 · Next: ‘8-K’ on / for 8/4/22 · Latest: ‘8-K’ on / for 5/8/24

Current Report — Form 8-K

Filing Table of Contents

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference